The Relevance of Iron in Erythropoietin-Stimulated Erythropoiesis
Author:
- Lawrence Tim GoodnoughLGLawrence Tim Goodnough
- 1 October 2006
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 43, S3-S8
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Intravenous Iron Optimizes the Response to Recombinant Human Erythropoietin in Cancer Patients With Chemotherapy-Related Anemia: A Multicenter, Open-Label, Randomized TrialJournal of Clinical Oncology, 2004
- Inadequate erythropoietin response to anemia: definition and clinical relevanceAnnals of Hematology, 1994
- A phase III trial of recombinant human erythropoietin therapy in nonanemic orthopedic patients subjected to aggressive removal of blood for autologous use: dose, response, toxicity, and efficacyTransfusion, 1994
- Preoperative red cell production in patients undergoing aggressive autologous blood phlebotomy with and without erythropoietin therapyTransfusion, 1992
- The effect of oral iron supplementation on erythropoiesis in autologous blood donorsTransfusion, 1992
- Erythropoietin Treatment of Anemia Associated with Multiple MyelomaNew England Journal of Medicine, 1990
- Red blood cell mass in autologous and homologous blood unitsTransfusion, 1989
- Increased Preoperative Collection of Autologous Blood with Recombinant Human Erythropoietin TherapyNew England Journal of Medicine, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987
- Perspectives in Iron MetabolismNew England Journal of Medicine, 1982